Bogdanet, Delia http://orcid.org/0000-0001-6127-5049
Castillo, Michelle Toth
Doheny, Helen
Dervan, Louise
Luque-Fernandez, Miguel Angel
Halperin, Jose A.
O’Shea, Paula M.
Dunne, Fidelma P.
Funding for this research was provided by:
Wellcome Trust (203930/B/16/Z)
National Institutes of Health (DK095424, DDK62294, DK089206, DK101442)
Article History
Received: 12 July 2022
Accepted: 27 September 2022
First Online: 29 October 2022
Declarations
:
: JAH has a financial interest in Mellitus LLC. Mellitus has licensed intellectual property for the technology used in this research and in developing diagnostic tools for diabetes. The interests of J.A.H. are reviewed and are managed by Brigham and Women's Hospital and Partners HealthCare in accordance with their conflict-of-interest policies. Reagents and laboratory analysis for pGCD59 were provided by Prof Jose A. Halperin.
: Ethical approval for this study was granted by the Clinical Research Ethics Committee, Galway, Ireland (Reference No- C.A. 2026).
: Informed consent was obtained from all participants in this study.